Phase Ib Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS(2021)
Abstract
In our phase IB study, the MTD dose of TAS-102 with concurrent liver RT is expected to be 30 mg/m. A phase II study is subsequently planned.
MoreTranslated text
Key words
hepatic metastases,colorectal cancer,radiation therapy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined